Human low molecular weight kininogen (LMWK) and high molecular weight kininogen (HMWK) have been purified to apparent homogeneity as intact, single-chain molecules. When they interacted with homologous urinary kallikrein, 0.9 mol of kinin per mol of substrate was released from LMWK and 0.7 mol of kinin per mol of substrate was released from HMWK. These functionally and structurally intact substrates have been used to obtain the kinetic constants for kinin release by purified human tissue kallikreins. With human urinary kallikrein, -apparent sec- (3, 5, (15) (16) (17) . Antibody specific for the human HMWK NH2-terminal chain recognizes both HMWK and LMWK, whereas antibody specific for the HMWK COOH-terminal chain recognizes only HMWK (18). Furthermore, the COOH-terminal chains of both bovine and human HMWK exhibit all the procoagulant activity of the intact molecule (2, 19, 20) whereas human and bovine LMWK lack this activity (10, 20), suggesting that the features that distinguish bovine HMWK and LMWK are also characteristics of human HMWK and LMWK. Glandular (tissue) kallikreins, which are found in kidney, pancreas, and salivary glands and in their secretions, are structurally, functionally, and antigenically different from plasma kallikrein but are related to each other (21-25). Glandular kallikrein has also been identified antigenically in human (26) and rat (27, 28) plasma, and the glandular kallikrein extracted from human plasma by a procedure that included immunoaffinity chromatography cleaved both synthetic substrates and HMWK (29). A single report (30) of the interaction of a glandular kallikrein-human salivary kallikrein-with human kininogen described the time-dependent cleavage of HMWK but did not present a detailed kinetic analysis or describe cleavage of LMWK.
ond-order rate constants (kcat/Km) of 1.46 X 105, 8 .6 X 104, and 5 .08 x 104 M-l s-were obtained with LMWK, HMWK, and a-N-p-tosyl-L-arginine methyl ester (TAMe), respectively; with human pancreatic kallikrein, values of 8.7 x 103 and 7.3 X 104 M-ls'-1 were obtained with HMWK and TAMe. These values, which are comparable to those obtained for other enzyme-protein substrate interactions, indicate that LMWK is only slightly preferred to HMWK as the natural substrate for urinary kallikrein and that HMWK is a somewhat better substrate for urinary kallikrein than for pancreatic kallikrein. Although the data obtained have been shown by NaDodSO4/polyacrylamide gel electrophoresis to reflect cleavage of the substrate at two points, the linear Lineweaver-Burk plots suggest that one cleavage is rate limiting. Because the plasma concentrations of both LMWK and HMWK are approximately 1/10th the Km values obtained, substrate concentration may also play a role in determining the rate at which tissue kallikreins release kinins from kininogen substrates either in the circulation or extravascularly.
Kininogens are plasma proteins that contain the peptide sequence of the vasoactive kinin polypeptides bradykinin (BK) and lysyl-BK. These peptides are released from their precursor molecules by limited proteolysis by enzymes known as kallikreins or kininogenases (EC 3.4.21.8). Human plasma contains two distinct forms of kininogen with M, 120,000 (1) (2) (3) (4) (5) and 50 ,000-80,000 (6) (7) (8) (9) , designated high molecular weight kininogen (HMWK) and low molecular weight kininogen (LMWK), respectively. HMWK, together with either plasma prekallikrein or factor XI, is an important component in contact activation of the Hageman factor-dependent pathways (10) (11) (12) (13) and, in contrast to LMWK (6, 8) , serves as a substrate for both tissue and plasma kallikreins.
The kinin moiety is located internally in bovine HMWK and LMWK, and its release from HMWK by bovine plasma kallikrein and from LMWK by snake venom kininogenase results in the formation of two-chain disulfide-linked "kinin-free" kininogens (14) . The NH2-terminal chains (termed "heavy chains") of the cleaved bovine HMWK and LMWK appear, by size, amino acid composition, and antigenic analysis, to have a high degree of homology, whereas their COOH-terminal chains ("light" chains) are clearly different by the same criteria. Cleavage of human HMWK by human plasma kallikrein or tissue kallikreins from saliva and urine also results in the formation of a two-chain, disulfide-linked kinin-free HMWK (3, 5, (15) (16) (17) . Antibody specific for the human HMWK NH2-terminal chain recognizes both HMWK and LMWK, whereas antibody specific for the HMWK COOH-terminal chain recognizes only HMWK (18) . Furthermore, the COOH-terminal chains of both bovine and human HMWK exhibit all the procoagulant activity of the intact molecule (2, 19, 20) whereas human and bovine LMWK lack this activity (10, 20) , suggesting that the features that distinguish bovine HMWK and LMWK are also characteristics of human HMWK and LMWK. Glandular (tissue) kallikreins, which are found in kidney, pancreas, and salivary glands and in their secretions, are structurally, functionally, and antigenically different from plasma kallikrein but are related to each other (21) (22) (23) (24) (25) . Glandular kallikrein has also been identified antigenically in human (26) and rat (27, 28) plasma, and the glandular kallikrein extracted from human plasma by a procedure that included immunoaffinity chromatography cleaved both synthetic substrates and HMWK (29) . A single report (30) of the interaction of a glandular kallikrein-human salivary kallikrein-with human kininogen described the time-dependent cleavage of HMWK but did not present a detailed kinetic analysis or describe cleavage of LMWK.
The difficulty in purifying LMWK as a fully active molecule free of albumin (31) , some a-globulins of similar size and charge (32) , and plasminogen (33, 34) has precluded adequate kinetic studies of human LMWK-enzyme interactions. Hence, the previous studies with human LMWK have used partially purified kininogen isolated under denaturing conditions (33, 34) . Purification of human LMWK to apparent homogeneity by a reproducible six-step procedure (9) and the availability of apparently homogeneous human HMWK (5) and tissue kallikreins (35) (36) (37) (46) . Human pancreatic kallikrein (HPK) was purified from pancreas obtained at autopsy within 6 hr of death. Homogenization, freeze-thawing, and isoelectric precipitation were performed as described (36) . The supernatant from the isoelectric precipitation step, which contained all the detectable glandular kallikrein antigen as assessed by Ouchterlony diffusion against anti-urokallikrein (47), was filtered on lima bean trypsin inhibitor-CH-Sepharose to remove remaining trypsin and chymotrypsin and then subjected to chromatography on hydroxylapatite (37) . The active fractions were pooled, concentrated, and subjected to aprotinin-CH-Sepharose affinity chromatography and Sephadex G-100 gel filtration as described (36 (5) .
The initial stepwise QAE-Sephadex A-50 fractionation of inhibitor-treated plasma also yielded a pool of LMWK as defined by the capacity to release kinin in the presence of HUK and to be immunoprecipitated by anti-kininogen antiserum (31) and by the failure to correct the coagulation defect in HMWK-deficient plasma (9) . In the six-step LMWK isolation procedure, which was carried out entirely between pH 7 and 8, the QAESephadex chromatography was followed by reverse ammonium sulfate gradient solubilization, hydrophobic chromatography on phenyl-Sepharose, gel filtration through Sephadex G-200, and removal of the remaining contaminants by binding them to AffiGel blue and to zinc (9) . The specific functional activity of the purified human LMWK was 0.8 mol of kinin per mol of substrate after a 5-min incubation with HUK and 0.9 mol/mol after a 30-min incubation. On alkaline polyacrylamide gel electrophoresis of 18 ,g of the purified human LMWK, the position of the single stained protein band corresponded to the only region of the replicate gels from which functional substrate could be eluted. Twenty-two micrograms of unreduced LMWK appeared as a single stained band of Mr 65,000 on NaDodSO4/ polyacrylamide gel electrophoresis. With reduction, the mobility of the protein reflected a Mr of 68,000, further indicating that the LMWK was purified as the intact single polypeptide chain.
RESULTS
The rate of kinin release from HMWK and LMWK by glandular kallikreins was determined by mixing prewarmed reagents and incubating them at 37°C and pH 8.0 (0.1 M Tris.HCl) for various times. With either substrate, a linear relationship between kinin release and incubation time was obtained beyond the 5-min incubation period usually used for further experiments. To determine the pH dependence, replicate samples of HMWK (25 ,ul) and LMWK (50 ,ul) Enzyme and substrate were incubated together at the indicated pH (s) or the enzyme was preincubated at the indicated pH and allowed to react with substrate at pH 8.8 ().
When HUK was used as the enzyme, there was a sharp optimum for generation of kinin at pH 8.8 with either HMWK (Fig.  1) or LMWK (Fig. 2) as the substrate. When HPK and HMWK were incubated together at various pH values, there was a broad peak of kinin release between pH 7.9 and 9.6 (Fig. 3) . Preincubation of HUK at the different pH values followed by interaction with substrate at pH 8.8 yielded maximal activity between pH 4.0 and 12.0 (Fig. 1) . In contrast, preincubation of HPK before interaction with HMWK at pH 8.8 showed a marked loss of activity below pH 6.5 (Fig. 3) .
With 4 Upper and with HPK in Fig. 4 Lower. Velocity is given as mol of BK equiv. generated per min per mg of enzyme. From these calculated plots the kinetic constants were determined (Table   1) . 50 ,ul with the same buffer. A Lineweaver-Burk plot in which velocity is given as mol of BK equiv. generated per min per mg of enzyme is shown in Fig. 5 and the kinetic constants for HUK are given in Table 1 .
DISCUSSION
The availability of HMWK and LMWK, purified to apparent homogeneity as single-chain proteins (5, 9) that were fully active with homologous tissue kallikreins (35) (36) (37) (Fig. 4) 
